Reinhard Ambros

Reinhard Ambros

Director/Board Member at REIN THERAPEUTICS INC.

Net worth: - $ as of 30/10/2026

70 year
Health Technology
Commercial Services
Finance

Profile

Reinhard J.
Ambros
is currently Chairman at ImmunOs Therapeutics AG since 2026.
Holds director positions at Cylene Pharmaceuticals, Inc., Artidis AG, and Viridos, Inc. (since 2018).
Serves as Lead Independent Director at Rein Therapeutics, Inc. since 2018.
Former roles include Chairman at Genedata AG and Versameb AG.
Served as Director at Forma Therapeutics, Inc., Aerpio Therapeutics LLC, ESBATech (a Novartis Co. GmbH), Microchips Biotech, Inc., Symetis SA, and Novartis Bioventure Fund as Managing Director.
Was Independent Director at Tokai Pharmaceuticals, Inc. (2014) and Affluent Medical SA. Held positions at Novartis Corp.
and Novartis AG as Head of Strategic Planning (2001-2005), President of Novartis Venture Fund (2017), and Global Head of Business Development & Licensing at Novartis Pharma AG (2001-2005).
Education includes graduate and doctorate degrees from the University of Regensburg.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/05/2026 0 ( -.--% ) - $ 30/10/2026

Reinhard Ambros active positions

CompaniesPositionStart
REIN THERAPEUTICS INC. Director/Board Member 31/05/2013
Chairman 31/12/2018
Director/Board Member -
Director/Board Member 24/06/2018
Director/Board Member -

Former positions of Reinhard Ambros

CompaniesPositionEnd
Chairman 04/12/2023
Private Equity Investor 30/08/2017
Director/Board Member 15/10/2014
Corporate Officer/Principal 31/12/2004
░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Reinhard Ambros's experience

Education of Reinhard Ambros

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Technology Services

Finance

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Reinhard Ambros